In general, CAAs increase the release of specific cytokines to activate the PI3K-AKT axis and HIF-1α or recruit TAMs to inhibit the expression of p53, which increase the expression of glucose transporters and glycolysis-related enzymes to promote the “Warburg effect” in BC cells. The gene discussed is AKT1; the disease is breast cancer.